← back to search

Liyan Chen

Nantong University · CN
🔎 Find collaborators in Cancer Research · Toxicology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Toxicology
Research interest
Research focused on Endoplasmic reticulum and GSK-3, with related work in Coronavirus disease 2019 (COVID-19), Gene signature, Minimal residual disease. Notable publications include 'Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis', '<p>Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma...', and 'Analysis of Risk Factors for the Thromboembolic Events from 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Report'.
h-index
citations
76
works
4
NIH funding
primary concept
email

Recent publications

Using RNA-seq for detecting MRD in multiple myeloma: high sensitivity and prognostic value
Cancer Gene Therapy 2025cited by 1position: middledoi
A ferroptosis associated gene signature for predicting prognosis and immune responses in patients with colorectal carcinoma
Frontiers in Genetics 2022cited by 11position: middledoi
Analysis of Risk Factors for the Thromboembolic Events from 88 Patients with COVID-19 Pneumonia in Wuhan, China: A Retrospective Report
SSRN Electronic Journal 2020cited by 12position: middledoi
<p>Expression of endoplasmic reticulum oxidoreductase 1-α in cholangiocarcinoma tissues and its effects on the proliferation and migration of cholangiocarcinoma cells</p>
Cancer Management and Research 2019cited by 21position: middledoi
Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis
PLoS ONE 2012cited by 52position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Haiyan Zhang · Shandong University of Traditional Chinese Medicine1 papers (2012–2012)Haifeng Xu · Nantong University1 papers (2022–2022)Huiqing Li · National Heart Lung and Blood Institute1 papers (2020–2020)Yinglan Jin · Harbin Medical University1 papers (2025–2025)Zhaoguo Li · Harbin Medical University1 papers (2020–2020)Kenichi Harada · Takara (Japan)1 papers (2019–2019)Shuai Zhao · Guangzhou University of Chinese Medicine1 papers (2020–2020) · 1 papers (2019–2019)Biqing Han · Harbin Medical University1 papers (2025–2025)Qiyun Tang · Xinxiang Medical University1 papers (2022–2022)Jundong Jiao · Harbin Medical University1 papers (2020–2020)Hanzhen Ji · Nantong University1 papers (2022–2022)Tao Wen · Capital Medical University1 papers (2012–2012)Dandan Yao · Nanjing University of Chinese Medicine1 papers (2025–2025)Liqian Yu · Harbin Medical University1 papers (2025–2025)Tesi Liu · The First Affiliated Hospital, Sun Yat-sen University1 papers (2019–2019) · 1 papers (2012–2012)Hongxing Liu · Sinopec (China)1 papers (2025–2025)Jiancheng Fang · Zhejiang Sci-Tech University1 papers (2025–2025)Sujun Zheng · Hubei University of Medicine1 papers (2012–2012)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Toxicology →